Viewing Study NCT01755767


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-02-18 @ 10:42 AM
Study NCT ID: NCT01755767
Status: COMPLETED
Last Update Posted: 2021-04-06
First Post: 2012-12-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy
Sponsor: Daiichi Sankyo
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MET diagnostic-high View
None Unresectable View
None Hepatocellular View
None Carcinoma View
None c-Met inhibitor View